140 related articles for article (PubMed ID: 8516941)
1. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
Collins BH; Areford ML; Fabian MA; Jaffee BD; Bollinger RR
Transplant Proc; 1993 Jun; 25(3 Suppl 2):37-9. PubMed ID: 8516941
[No Abstract] [Full Text] [Related]
2. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
3. Evidence that 2-chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
Oberhuber G; Schmid T; Thaler W; Kaltenbacher A; Schirmer M; Liliemark J; Herbst P; Geisen F; Margreiter R; Konwalinka G
Transplantation; 1994 Sep; 58(6):743-5. PubMed ID: 7940703
[No Abstract] [Full Text] [Related]
4. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
[No Abstract] [Full Text] [Related]
5. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
[No Abstract] [Full Text] [Related]
7. 2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
Schmid T; Oberhuber G; Thaler W; Kaltenbacher A; Herbst P; Margreiter R; Konwalinka G
Transplant Proc; 1994 Jun; 26(3):1614. PubMed ID: 7913269
[No Abstract] [Full Text] [Related]
8. Oral leflunomide prevents small bowel allograft rejection in the rat.
He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
[No Abstract] [Full Text] [Related]
9. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
Marquet RL; de Bruin RW; Heineman E; Jeekel J
Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
[No Abstract] [Full Text] [Related]
10. Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
Cosenza CA; Tuso PJ; Chapman FA; Middleton YD; Cramer DV; Wu GD; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):59-60. PubMed ID: 8516946
[No Abstract] [Full Text] [Related]
11. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
Knoop M; Cramer DV; Chapman FC; Makowka L
Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
[No Abstract] [Full Text] [Related]
12. Immunosuppressive effects of leflunomide in a cardiac allograft model.
Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
[No Abstract] [Full Text] [Related]
13. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
Wang M; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
[No Abstract] [Full Text] [Related]
14. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
Knoop M; Cramer DV; Chapman FC; Makowka L
Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
[No Abstract] [Full Text] [Related]
15. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
Wang M; Stepkowski SM; Kahan BD
Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
[No Abstract] [Full Text] [Related]
16. Effect of brequinar sodium on in vivo antibody production.
Yasunaga C; Cramer DV; Cosenza CA; Tuso PJ; Chapman FA; Barnett M; Wu GD; Putnam BA; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):40-4. PubMed ID: 8516942
[No Abstract] [Full Text] [Related]
17. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
[No Abstract] [Full Text] [Related]
19. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
[No Abstract] [Full Text] [Related]
20. Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation.
Johnson S; Qi S; Xu D; Jolicoeur M; Liu D; Barama A; Busque S; Smeesters C; Daloze P; Chen H
Microsurgery; 2003; 23(5):476-82. PubMed ID: 14558006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
